Philogen up

Last week, angiogenesis-focused Philogen S.p.A. disclosed details of its IPO.

The Italian company plans to sell up to 10.7 million shares at €4.75-€6.10 in an IPO on the Milan Stock Exchange. That would raise up to €65.3 million ($88.9 million). The company pegged its pre-money valuation at €170.9-€219.5 million ($232.6-$298.8 million)...